Home LiteratureArticle Details
PMID: 8623910 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.

The American journal of pathology ·Vol. 148 ·No. 5 ·1996-05-00 ·Pages 1381-5

Goldman SC, Chen CY, Lansing TJ, Gilmer TM, Kastan MB

Abstract

Mutations of the p53 tumor suppressor gene are rarely found in neuroblastoma. Though typically a nuclear protein, a number of tumor cell types have recently been reported to exhibit cytoplasmic p53 immunostaining, and it has been suggested that altered cellular localization is another mechanism of inhibiting p53 function. We examined p53 protein expression, localization, and function in neuroblastoma cell lines with wild-type p53 genes. Basal p53 levels were largely confined to the cytoplasmic compartment in these cells. However, after irradiation, p53 protein levels increased predominately in the nucleus. Transcriptional activity of p53 was intact in these cells because "downstream" proteins, p21WAF1 and MDM2, were induced by irradiation. In contrast to a neuroblastoma cell line harboring a mutant p53 gene, the neuroblastoma cells with wild-type protein were associated with an intact G1 arrest after DNA damage. The induced nuclear protein in these neuroblastoma cells also appeared functional as measured by its capacity to bind to a DNA oligomer containing a p53-consensus sequence. We have concluded that although p53 expression in neuroblastoma cells is primarily localized to the cytosol, ionizing radiation induces a functional p53 protein in the nucleus and that this cytoplasmic sequestration of p53 in human neuroblastoma is not a mechanism of inactivating p53 function.

MeSH Terms
Blotting, Western Cell Cycle/radiation effects Cell Fractionation Cell Nucleus/chemistry Cytoplasm/chemistry DNA Damage DNA, Neoplasm/analysis,genetics Genes, Tumor Suppressor/genetics Genes, p53/radiation effects Humans Immunohistochemistry Neuroblastoma/chemistry,pathology Point Mutation Polymerase Chain Reaction Signal Transduction/physiology Tumor Cells, Cultured Tumor Suppressor Protein p53/analysis,genetics,physiology
Chemicals
DNA, Neoplasm Tumor Suppressor Protein p53
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Goldman S C
Johns Hopkins Oncology Center, Baltimore, Maryland, USA.
Chen C Y
Lansing T J
Gilmer T M
Kastan M B
References (14)
14 references, click to expand
  1. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  2. Levels of p53 protein increase with maturation in human hematopoietic cells.
    Cancer Res. 1991 Aug 15;51(16):4279-86 PMID: 1868448
  3. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6 PMID: 1353891
  4. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 PMID: 1323840
  5. Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.
    Cell Growth Differ. 1993 May;4(5):349-57 PMID: 8518229
  6. Absence of p53 gene mutations in primary neuroblastomas.
    Cancer Res. 1993 Nov 1;53(21):5269-73 PMID: 8221661
  7. P53, cell cycle control and apoptosis: implications for cancer.
    Cancer Metastasis Rev. 1995 Mar;14(1):3-15 PMID: 7606818
  8. Low frequency of the p53 gene mutations in neuroblastoma.
    Cancer. 1994 Jun 15;73(12):3087-93 PMID: 8200007
  9. No TP53 mutations in neuroblastomas detected by PCR-SSCP analysis.
    Genes Chromosomes Cancer. 1994 Jun;10(2):136-8 PMID: 7520267
  10. p53-dependent apoptosis suppresses tumor growth and progression in vivo.
    Cell. 1994 Aug 26;78(4):703-11 PMID: 8069917
  11. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.
    Cancer Res. 1994 Oct 1;54(19):5054-8 PMID: 7923116
  12. Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
    EMBO J. 1994 Oct 17;13(20):4816-22 PMID: 7957050
  13. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
    Proc Natl Acad Sci U S A. 1995 May 9;92(10):4407-11 PMID: 7753819
  14. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Cancer Res. 1993 Nov 1;53(21):5284-8 PMID: 8221663
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1996-05-00
Pages
1381-5
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1861565
Subset
IM
Grants
NIEHS NIH HHS · ES0577 · United States
NCI NIH HHS · T32CA60441 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com